Divestiture Trust Biotest serves as Executive at ADMA BIOLOGICS, INC., where they oversee executive responsibilities. Since joining the company, Divestiture Trust Biotest has executed 2 insider transactions totaling $21.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 6, 2019 involved selling 5,813,954 shares valued at $21.8M.
Divestiture Trust Biotest currently holds 4,295,580 shares of ADMA BIOLOGICS, INC. (ADMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Divestiture Trust Biotest has been a net seller of ADMA stock. They have purchased $0 and sold $21.8M worth of shares.
Divestiture Trust Biotest's most recent insider trade was on Jun 6, 2019, when they sold 5,813,954 shares at $3.75 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |